SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " disease " 2,138 found 🔀 AI-powered Shuffle
How expert guidelines have influenced TAVR vs. SAVR decisions
As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease.
Woman shares lifelong Lyme disease struggle as health officials urge tick awareness in Mid-Ohio Valley
Woman shares lifelong Lyme disease struggle as health officials urge tick awareness in Mid-Ohio Valley
Health officials warn of potential measles exposure at Roslyn Heights restaurant
A laboratory verified a measles case in a New York City resident, who potentially exposed the highly contagious disease to patrons who visited the 388 Italian Restaurant in Roslyn Heights on May 3.
Hantavirus misinformation runs rampant as the US is unequipped to respond to infectious disease health scare
But the US’s withdrawal from the WHO – and cuts to the country’s health system – stymie officials’ response
Metabolic liver disease to hit 1.8bn by 2050, and other health stories
Top health news: Metabolic liver disease is on the rise; Global pandemic treaty deadline missed again; Hantavirus cases linked to cruise ship.
WOAH Statement on Hantavirus - WOAH - World Organisation for Animal Health
Hantavirus is a zoonotic disease, meaning it originates in animals — primarily rodents — before crossing into human populations.
New obesity discovery rewrites decades of fat science
Scientists have uncovered a surprising secret hidden inside fat cells that could reshape how we think about obesity and metabolic disease. A protein called HSL, long believed to simply release stored fat when the body needs energy, turns out to have a second job deep inside the nucleus of fat cells—helping keep those cells healthy and balanced. Even more surprising, people and mice missing this protein don’t become obese as expected; instead, they lose fat tissue in a dangerous condition called lipodystrophy.
Public health officials warn of rise in measles, as Va. hantavirus patient under monitor
As summer travel season is a factor in disease spread, state and federal government leaders offer guidance and resources.
Hantavirus: the risks, the science and what you need to know
On May 2, the World Health Organization got an alarming report: People aboard a ship in the Atlantic Ocean were falling ill. The culprit is now confirmed as hantavirus, a pathogen that some rodents carry that can infect humans in rare, but often deadly, instances. Multiple passengers have died, and more people are showing symptoms. So, we’re talking to Emily Abdoler, an infectious disease doctor at the University of Michigan, about the news – how common is hantavirus in humans, what are the consequences of getting it, and how can at-risk people protect themselves from it? If you found this episode interesting, listen to our episode on Rocky Mountain spotted fever.Interested in more science in the news? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
Scientists discover a new way to prevent gum disease without killing good bacteria
Scientists have uncovered a surprising way to influence the bacteria living in our mouths — not by killing them, but by interrupting how they “talk” to each other. Researchers found that dental plaque bacteria use chemical signals to coordinate growth, and by blocking those signals, they were able to encourage healthier bacteria while reducing disease-linked microbes tied to gum disease. Even more intriguing, the bacterial conversations changed depending on oxygen levels above and below the gums, revealing an entirely new layer of complexity inside the mouth.
Cleveland Clinic Releases New National Report on the State of Women’s Health in the U.S.
Findings show many women are more concerned about affording care than developing serious diseases — with gaps in prevention and clear information shaping their decisions
Hantavirus - Statement from the Virginia Department of Health - Virginia Department of Health
As of May 7, 2026, please see the Virginia Department of Health’s statement: The Virginia Department of Health is monitoring this situation closely and has been in active communication with our federal partners at the Centers for Disease Control and Prevention (CDC). To date, one Virginia traveler who was on the MV Hondius disembarked the ship and has […]
Hantavirus Pulmonary Syndrome (HPS) - Statement from the Virginia Department of Health - Virginia Department of Health
As of May 7, 2026, please see the Virginia Department of Health’s statement below: The Virginia Department of Health is monitoring this situation closely and has been in active communication with our federal partners at the Centers for Disease Control and Prevention (CDC). To date, one Virginia traveler who was on the MV Hondius disembarked the ship […]
The National Academy of Sciences Elects Two Berkeley Lab Researchers
Two Lawrence Berkeley National Laboratory (Berkeley Lab) scientists have been elected to the National Academy of Sciences (NAS) in recognition of their distinguished and continuing achievements in original research. They are part of a cohort of 120 new members and 25 international members. The National Academy of Sciences is a private, nonprofit institution that was established under a congressional charter signed by President Abraham Lincoln in 1863. It recognizes achievement in science by election to membership, and — alongside the National Academy of Engineering and the National Academy of Medicine — provides science, engineering, and health policy advice to the federal government and other organizations. The 2026 electees bring the total number of active members to 2,705 with 557 international members. Gary Karpen is a biologist senior faculty scientist in Berkeley Lab’s Biological Systems and Engineering Division and a Professor of Cell and Developmental Physiology in the Department of Molecular and Cell Biology at UC Berkeley. Karpen studies how the structure, organization, and maintenance of genetic material impact inheritance and cell function. His lab focuses on chromatin — a packaged form of DNA strands wrapped around proteins that comprises our chromosomes — with a particular emphasis on centromeres, rarely expressed sequences called heterochromatin, DNA repair, and regulatory RNAs. His research reveals insights into fundamental aspects of nuclear organization and genome regulation that are shared across the tree of life, broadening our understanding of cancer and other diseases, birth defects, and aging. Kam-Biu Luk is a Professor Emeritus of physics at UC Berkeley and a retired senior faculty scientist in Berkeley Lab’s Physics Division. He is an experimental particle physicist whose research has focused on neutrinos: nearly massless, electrically neutral elementary particles that can pass through matter virtually undetected. Neutrinos are created during radioactive decay processes, including the fusion process occurring in stars and the fission process that powers nuclear reactors. Luk initiated and co-led the Daya Bay Reactor Neutrino Experiment, a project based in China with more than 200 international collaborators. In 2012, the Daya Bay experiment discovered a new form of a phenomenon called “neutrino oscillation” in which neutrinos change from one type to another. For this discovery, Luk and his collaborator Yifan Wang received the 2014 American Physical Society Division of Particles and Fields W.K.H. Panofsky Prize for outstanding work in experimental particle physics, and he was also the co-recipient of the 2016 Breakthrough Prize. Luk is currently participating in the Deep Underground Neutrino Experiment (DUNE) hosted by Fermi National Accelerator Laboratory, which will investigate any potential difference in behavior between neutrinos and antineutrinos that may shed light on the evolution of the universe, especially why antimatter is absent in the present universe. ### Lawrence Berkeley National Laboratory (Berkeley Lab) is committed to groundbreaking research focused on discovery science and solutions for abundant and reliable energy supplies. The lab’s expertise spans materials, chemistry, physics, biology, earth and environmental science, mathematics, and computing. Researchers from around the world rely on the lab’s world-class scientific facilities for their own pioneering research. Founded in 1931 on the belief that the biggest problems are best addressed by teams, Berkeley Lab and its scientists have been recognized with 17 Nobel Prizes. Berkeley Lab is a multiprogram national laboratory managed by the University of California for the U.S. Department of Energy’s Office of Science. DOE’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit energy.gov/science.
New WAM Grants Support Research on Gut-Brain Interactions, Menopause and Sarcopenia
The Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic has awarded grants for promising research in sex-based differences in the disease.
These companies help parents try to pick their babies' traits. Experts are wary
Prospective parents can now pick embryos based on risk predictions for thousands of diseases and odds for specific traits. But should they?
Canary Islands refuses to allow MV Hondius with hantavirus to dock
Three people have died from the disease so far but the WHO says the risk to the public is still 'low'.
Eggs and brain health: New study cracks open Alzheimer’s link
A long-term study suggests that eating eggs regularly may be associated with a lower risk of developing Alzheimer’s disease in older adults.
New AI method tackles one of science’s hardest math problems
Penn researchers have developed a smarter AI method for solving notoriously difficult inverse equations, which help scientists uncover hidden causes behind observable effects. By introducing “mollifier layers” that smooth noisy data, they’ve made these calculations more stable and far less computationally demanding. This could transform fields like genetics, where understanding how DNA behaves is key to disease research.
Maryland health officials launch tickborne disease prevention campaign
As warmer weather brings more Marylanders outdoors, the Maryland Department of Health (DOH) is urging residents to take precautions to prevent tick bites and ti
Science communication as feedback loop explored at annual ethics symposium
The annual Ethics and Compliance Symposium brought renowned vaccinologist Peter Hotez, senior fellow in disease and humanity at Rice University’s Baker Institute for Public Policy, to share his research and discuss the ethics of academic public engagement.
Pages - Maryland Department of Health urges Marylanders to protect against tickborne diseases
An official website of the State of Maryland.
US Adults Interested in, but Lack Knowledge About, Brain Health
US adults show strong interest in brain health, but very few report knowing a lot about ways to maintain a healthy brain.
Man destined to get Alzheimer’s saved by accidental heat therapy
Doug Whitney has a genetic mutation that means he should have developed Alzheimer’s disease decades ago, but his long-term work in hot engine rooms may have protected him in a similar way to sauna therapy
Aetna Better Health® of Louisiana collaborates with Goodr to launch mobile food market and chronic care program
Aetna Better Health® of Louisiana partners with Goodr to expand food access and support chronic disease management for communities across Louisiana.
Tennessee Department of Health issues tick-bite prevention tips amid national case rise
The Tennessee Department of Health is reminding everyone to take precautions to avoid tick bites and tick-borne diseases.This comes as recent nationwide numbers
Zuckerberg Trying to Simulate Human Biology at the Cellular Level
The Chan Zuckerberg Biohub says its goal is to cure all human diseases with the power of artificial intelligence.
Corteva's seed business to be named Vylor following planned 2026 separation
Corteva has renamed its seed and genetics business Vylor. In a statement, the company says the new division will further strengthen gene editing and disease resistance, while also helping farmers explore new row crop opportunities. Corteva says the overall restructuring is designed to capitalize on investments in biological and differentiated crop protection products, while also […]
This simple amino acid supplement greatly reduces Alzheimer’s damage
A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of toxic amyloid proteins in the brain, a hallmark of the disease. In animal models, oral arginine not only lowered harmful protein deposits but also improved behavior and reduced brain inflammation.
Iterative Health Reports Expanded Trial Performance Data at Digestive Disease Week 2026, Demonstrating Consistent Outperformance of Industry Benchmarks at Double the Scale
CAMBRIDGE, Mass., May 04, 2026--Iterative Health announced the presentation of updated scientific research at Digestive Disease Week (DDW) 2026.
Global webinar – From evidence to essential services: embedding harm reduction in national health systems
Harm reduction services remain underfunded, fragmented, and often outside mainstream health systems, despite being an evidence-based, rights-based, and cost-effective approach, essential for achieving global HIV, hepatitis, and universal health coverage goals. This webinar will present WHO guidance and effective harm reduction approaches and respond to growing demand for practical dialogue on how to translate evidence into scalable national service models.
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
4D mammo may be up to four times more accurate than 3D
The 4D system harnesses X-ray diffraction to measure molecular-level signatures of disease; these tissue “fingerprints” could help providers diagnose breast cancer in its earliest stages.
Missed Sexual Health Assessment May Limit Clinical Insight
New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.
Black maternal health, systemic issues Black women face in health care & the real world consequences
In this edition of Real Conversations in the QC, the cast sat down with community members and local experts to break down disease and healthcare issues that often affect the Black community.
Black maternal health, systemic issues Black women face in health care & the real world consequences
In this edition of Real Conversations in the QC, the cast sat down with community members and local experts to break down disease and healthcare issues that often affect the Black community.
Malaria didn’t just kill early humans, it shaped who we became
Long before humans spread across the globe, a deadly disease may have quietly shaped where our ancestors lived—and even how we evolved. New research reveals that malaria didn’t just threaten early human survival; it actively pushed populations away from high-risk regions across Africa, fragmenting groups over tens of thousands of years. This separation influenced how different populations met, mixed, and exchanged genes, helping shape the genetic diversity we see today.
NYC hospitals gearing up for nightmarish World Cup diseases as fans descend on metro
Hospitals in New Jersey and New York, along with millions of their medical personnel, have been undergoing intense training for the past two years to deal with the 1.2 million people from around the...
Doctors Say This Cooking Mistake Could Be Harming Your Health
Doctors share how oversalting your food could increase your risk for heart disease, plus ways to cut back while still enjoying flavorful meals at home.
From brain health to diabetes: 3 reasons to get your vitamin D levels checked
In this study roundup, Medical News Today compiles the latest evidence on the benefits of Vitamin D, focusing on the key findings from 3 studies on diabetes, IBD, Alzheimer's disease.
Syphilis making a comeback, health officials warn. CDC map shows where risk is highest
Compared to about a decade ago, the Centers for Disease Control and Prevention said congenital syphilis cases are 700% higher nationwide.
From Sick Care to Whole Health: 5 Forces Reshaping the Future of Healthcare
/PRNewswire/ -- Healthcare is entering a new era—one that moves beyond treating disease to addressing the full complexity of human health and well-being....
AI Can Spot Pancreatic Cancer Years Before Diagnosis, Study Finds
Catching this deadly disease while it's treatable can save lives.
Health officials monitor West Valley neighborhood for possible Parkinson's disease cases
A neighborhood has been monitored by Utah health officials for possible cases of Parkinson's disease.The officials emphasized that the effort is in an early dat
New treatment cuts bad cholesterol by nearly 50% without statins
A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.
The CDC warns tick season is off to a strong start this spring
Tick-related ER visits are higher than normal this year. Here’s how you can protect yourself and your family from Lyme disease.
New York Issues Warning on Lyme Disease as Warm Weather Approaches
Health and environmental officials are urging New Yorkers and visitors to protect themselves from ticks and tick-borne diseases as the weather gets warmer.
Baptist Health to lay off 150 at Fort Smith campus amid restructuring
Baptist Health is laying off 150 employees at its Fort Smith campus as they undergo a strategic restructuring to cope with financial loss.
News Anchors Who Have Shared Their Health Struggles
Robin Roberts, Amy Robach and others in the news media have opened up about their personal health struggles to raise awareness of preventable diseases, encourage screenings, and at times, explain on-air symptoms.
Surprising obesity discovery rewrites decades of fat metabolism science
A key protein involved in fat metabolism has been found to do more than scientists once thought. Instead of just releasing fat, it helps maintain healthy fat tissue and balance in the body. When it’s missing or disrupted, the results can be surprisingly harmful. This finding reshapes how researchers think about obesity and metabolic disease.
Health Care Affordability in the United States, From Crisis to Action
U.S. health care costs exceed $5T yearly, driving delayed care and debt. Experts urge reforms to improve affordability, access, and health outcomes. delivery of health care; financial stress; health care costs; health policy; patient advocacy
VCU Health, Richmond leaders break ground on Pauley Heart Center Pavilion
VCU Health and Richmond leaders broke ground on the new Pauley Heart Center Pavilion, taking one step towards tackling heart disease.
Protecting the Health of Black Children
Failure to understand the history of vaccine-preventable diseases risks dooming US children to again suffer needlessly from preventable infections
Why science diplomacy matters for infectious disease prevention, global progress
Amita Gupta, director of the Division of Infectious Diseases at Johns Hopkins, explains why global collaboration—among governments and beyond—is key to scientific advancement and health security.
2 UVA scientists elected to American Academy of Arts & Sciences
The UVA researchers were elected for their work advancing understanding of disease and environmental challenges.
Should We Use Science to Edit Human Life? Watch the Debate
Gene editing of human embryos could prevent serious genetic disease and improve quality of life in unprecedented ways. But it also raises major ethical concerns.
Certain Floridians die more often of cancer and disease. Will AI make it worse?
More Hispanics in Florida went without healthcare in 2023 and 2024 at higher rates than the Black and white populations.
Significant rise in valley fever cases in El Paso linked to extreme weather, dust, study finds
A new study by researchers at The University of Texas at El Paso has identified a significant rise in Valley fever cases in El Paso over the past decade and found strong connections between the disease ...
Damon Wayans reveals the scary symptom that led to his type 2 diabetes diagnosis
Damon Wayans details his type 2 diabetes journey, the symptoms that alarmed him and his new partnership to raise awareness for the diabetic eye disease DME.
Australia becomes the 30th country to eliminate trachoma as a public health problem
The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs). Trachoma, the world’s leading infectious cause of blindness, no longer represents a public health problem in the country.Australia is among a growing number of countries that have successfully eliminated trachoma, contributing to global progress towards the targets set out in the WHO road map for NTDs 2021–2030.Trachoma is caused by the bacterium Chlamydia trachomatis and spreads through close contact with infected individuals, contaminated surfaces, and flies that carry eye and nose discharge. Repeated infections can lead to scarring of the eyelids, turning eyelashes inward, and ultimately causing blindness if untreated.“WHO congratulates Australia on this important achievement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This success reflects sustained commitment, strong partnerships, and a focus on reaching populations most affected by health inequities. It brings us closer to a world free from the suffering caused by trachoma.”Australia’s journey to eliminationAustralia’s achievement reflects decades of targeted public health action, particularly in remote Aboriginal and Torres Strait Islander communities, where trachoma persisted despite its earlier disappearance from the rest of the country.National efforts intensified with the establishment of the National Trachoma Management Programme in 2006, which implemented the WHO-recommended SAFE strategy: surgery for trichiasis, antibiotics to treat infection, promotion of facial cleanliness, and environmental improvement. Regular screening of all communities classified as at-risk of trachoma by teams of qualified health workers formed an important part of the Programme. Interventions were delivered through coordinated partnerships between federal and state governments, Aboriginal community-controlled health services, and local communities.Over time, sustained screening, treatment, and prevention activities, including improvements in housing, water, sanitation and hygiene, led to a steady decline in trachoma prevalence. Australia’s approach included adaptations to reflect its context, such as targeted treatment based on community-level data rather than mass drug administration, and strong integration with environmental health programmes.“Elimination of trachoma is a win for the eye health of communities across Australia, particularly those whose lives have been impacted by a disease that is entirely preventable,” said Mark Butler, Minister for Health and Ageing, Australia. “This major milestone is thanks to Aboriginal and Torres Strait Islander leadership, community commitment and sustained investment over many decades.“The lessons from this work will inform how we approach other preventable health conditions in remote and regional Australia. Aboriginal Community Controlled Health Organisations and local health workers have been central to this success, delivering culturally safe care and community-led solutions.”“This recognition from the World Health Organization reflects decades of work led by Aboriginal Community Controlled Health Organisations, alongside local health workers in remote First Nations communities,” said Malarndirri McCarthy, Minister for Indigenous Australians. “Their work has been critical to eliminating trachoma as a public health problem in Australia.”Advancing global efforts against neglected tropical diseases (NTDs)Trachoma is one of 21 diseases and disease groups that are regarded by WHO as NTDs. Together, NTDs affect more than 1 billion people worldwide, primarily in underserved populations with limited access to essential services such as clean water, sanitation, and health care.Australia’s elimination of trachoma as a public health problem highlights the importance of sustained political commitment and cross-sectoral collaboration in addressing the underlying determinants of health. It also underscores the feasibility of eliminating trachoma even in geographically challenging settings.In addition to trachoma, Australia has several endemic NTDs, including Buruli ulcer, leprosy and scabies. Validation of elimination of trachoma as a public health problem marks the first time that WHO has confirmed the elimination of an NTD in Australia, which becomes the 63rd country globally and 16th in the Western Pacific Region to have eliminated at least one NTD.“Tackling neglected tropical diseases in the Western Pacific Region has long been a challenge for countries across the socioeconomic spectrum, given the complexities in reaching the most vulnerable communities, including in remote areas,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “As a doctor from Tonga, I’ve experienced these challenges for myself. But I also know that with strategic commitment underpinned by optimal resources and partnerships in health, success is possible as other countries in our region have also demonstrated. I commend Australia on eliminating trachoma as a public health problem and urge all involved to remain vigilant to ensure this status is maintained.”WHO continues to support countries working to eliminate trachoma and other NTDs, ensuring that progress reaches those most in need and that gains are sustained through strong surveillance, appropriately integrated into national health systems, and mainstreamed within the wider health sector and beyond.Editor’s notesNeglected tropical diseases and trachoma elimination effortsNeglected tropical diseases are associated with devastating health, social and economic consequences. Their burden is mainly felt among impoverished communities in tropical areas.Public health targets for the control, elimination and eradication of these conditions were set in the road map for neglected tropical diseases 2021–2030 (https://www.who.int/publications/i/item/9789240010352).In 1996, WHO launched the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020), creating a network of governments, non-governmental organizations and academic institutions dedicated to the fight against trachoma. WHO continues to support endemic countries to accelerate progress towards the global target of eliminating trachoma as a public health problem worldwide; 2030 is the new target date.Elimination of trachoma as a public health problem is defined as: (i) a prevalence of trachomatous trichiasis (TT) “unknown to the health system” of < 0.2% in ≥15-year-olds; and (ii) a prevalence of trachomatous inflammation—follicular (TF) in children aged 1–9 years of < 5%, in each formerly endemic district, plus (iii) the existence of a system to identify and manage incident cases of TT.Other countries validated by WHO as having eliminated trachoma as a public health problem are: Algeria, Benin, Burundi, Cambodia, China, Egypt, Fiji, Gambia, Ghana, India, Iraq, Islamic Republic of Iran, Lao People’s Democratic Republic, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Vanuatu and Viet Nam.
Australia becomes the 30th country to eliminate trachoma as a public health problem
The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs). Trachoma, the world’s leading infectious cause of blindness, no longer represents a public health problem in the country.
Your Mouth Could Be Aging You Faster—The Hidden Health Risk
Your mouth may reveal more than your smile—experts link gum health to heart disease, inflammation, and aging. Here’s why oral care is key to longevity.
Texas A&M AgriLife launches national equine metabolic health survey
A Texas A&M AgriLife survey of horse owners and industry professionals seeks to quantify the prevalence of equine endocrine disease
Former Health Official Charged With Concealing Emails About Covid-19 Grants
David Morens, who was a senior adviser at the National Institute of Allergy and Infectious Diseases, is accused of evading document requests.
Tick Season is Here!
Did you know that the Iowa tick season starts in April? Ticks are common throughout the summer and often become less of a problem after cooler weather arrives. Ticks come in a variety of colors, sizes, and shapes. Some carry illness and disease so it’s important to check pets and people for ticks after being outside.
Neuroinfectious Diseases Research Workshop: Advancing Translational Science and Clinical Innovation
The Neuroinfectious Diseases Research Workshop will be a two-day scientific meeting designed to accelerate research, foster collaboration, and build capacity in the field of neurological infections. Hosted at the NIH Neuroscience Center (NSC, Executive Boulevard), this meeting will bring together clinician-scientists, laboratory investigators, translational researchers, government partners, and trainees committed to advancing understanding of neuroinfectious
MIT scientists turn chaotic laser light into powerful brain imaging tool
Scientists at MIT discovered that chaotic laser light can spontaneously form a highly focused beam instead of scattering—if the conditions are just right. This “pencil beam” enabled them to image the blood-brain barrier in 3D at speeds 25 times faster than existing techniques. The method also lets researchers watch how drugs move into brain cells in real time. It could dramatically accelerate the development of treatments for neurological diseases.
Africa CDC Launches African High-Level Ministerial Committee to Shape Global Health Architecture Reform
Nairobi, Kenya | 27 April 2026 — Africa Centres for Disease Control and Prevention (Africa CDC) today launched the African High-Level Ministerial Committee on Global Health Architecture Reform (AHLMC) on the margins of the World Health Summit Regional Meeting 2026 in Nairobi, Kenya. The Committee brings together Ministers of Health and Finance from across the continent to […]
Efforts to eliminate hepatitis delivers gains but more action needed to meet 2030 targets
Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health challenge, according to a new WHO report released today at the World Hepatitis Summit.
Plant and Soil Science Senior Advancing Sustainable Agriculture Research
Oscar Deleon is researching how beneficial fungi can combat crop disease and resistance, advancing sustainable agriculture while building a new future shaped by education, resilience, and scientific curiosity.
First Louisiana patient to receive sickle cell gene therapy heads home after 6 weeks in hospital
Learn about the groundbreaking gene therapy for sickle cell disease at Manning Family Children's Hospital in Louisiana, providing hope for a "functional cure".
Cellular Rejuvenation Has the Potential to Reverse Aging
A new therapy has the potential to cure hundreds of diseases — and even reverse aging.
UT Health San Antonio researchers awarded grant to study how circadian rhythm disruptions may contribute to Alzheimer’s - UT Health San Antonio
Environmental stressors like jet lag, high-fat foods suspected as disease risk Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, April 27, 2026 – Can jet lag cause more than just sleep loss? Do quick-grab, high-fat foods associated with late-night or rotating work shifts bring more than indigestion? Those circadian […]
Inside the endoscopic revolution in weight loss
Article explains how bariatric endoscopy — including endoscopic sleeve gastroplasty and transoral outlet reduction — combined with metabolic therapies and GLP-1 receptor agonists is expanding nonsurgical obesity treatment options and reframing obesity as a chronic, multifactorial disease.
Global Health Experts Urge Urgent Action to Prevent Future Pandemics Where They Begin
BRONX, NY, April 27, 2026—A new paper published in The Lancet calls on governments to prioritize preventing zoonotic disease spillover—the transmission of pathogens from animals to humans—as a central pillar of global pandemic preparedness, The authors argue that w
Practicing today for tomorrow’s emergencies – WHO convenes countries and partners to simulate response to major disease outbreak
WHO wrapped up Exercise Polaris II, a 2-day high-level simulation exercise, based around an outbreak of a fictional new bacterium spreading across the world. Bringing together 26 countries and territories, 600 health emergency experts and over 25 partners, the exercise allowed countries to test their preparedness for pandemics and other major health emergencies.
Most Americans value brain health, but a new Alzheimer's report finds few know how to protect it
According to the survey released this month, 9 in 10 adults aged 40 and older said brain health is a top priority, on par with physical health. But only about 1 in 10 actually know how to maintain it.
As heart, kidney and metabolic health worsen, cancer risk may rise
Research Highlights: Researchers studied the link between cardiovascular-kidney-metabolic syndrome (CKM syndrome) and risk of cancer. CKM syndrome refers to several connected health conditions, including heart disease, stroke, kidney disease, obesity...
An ancient disease is making a comeback, and every American should be concerned
The U.S. President’s Malaria Initiative has saved millions of lives and prevented billions of cases of malaria, but progress is slowing due to the disease evolving and the need for renewed em…
Brain health: Alzheimer's 2026 new report on cognitive impairment & dementia in Tennessee
An estimated 7.4 million Americans age 65 and older are now living with clinical dementia due to Alzheimer's disease, according to a newly released report from
Algeria eliminates trachoma as a public health problem
The World Health Organization (WHO) reports validating Algeria as having eliminated trachoma as a public health problem. This makes Algeria the 29th country globally to achieve this significant milestone. "Algeria’s elimination of trachoma is a historic triumph that connects the past, present, and future of public health, and is rooted in a century-long commitment," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "This milestone proves that with sustained political will and on-the-ground leadership from committed health professionals, we can eliminate neglected tropical diseases and build a healthier, more resilient future for all." For decades, Algeria implemented the WHO-recommended SAFE strategy to eliminate trachoma. These activities included provision of surgery to treat the late blinding stage of the disease (“trachomatous trichiasis”, TT), conducting mass administration of antibiotic treatment, carrying out public awareness campaigns to promote facial cleanliness and personal hygiene as well as improvement in access to water supply and sanitation. Trachoma is the first neglected tropical disease to be eliminated in Algeria. Trachoma is a disease of the eye caused by infection with the bacterium Chlamydia trachomatis. It is a public health problem in 30 countries and is responsible for the blindness or visual impairment of about 1.9 million people. Blindness from trachoma is difficult to reverse. Based on November 2025 data, 97 million people live in trachoma endemic areas and are at risk of trachoma blindness. Infection spreads through personal contact (via hands, clothes, bedding or hard surfaces) and by flies that have been in contact with discharge from the eyes or nose of an infected person. With repeated episodes of infection over many years, the eyelashes may be drawn in so that they rub on the surface of the eye. This causes pain and may permanently damage the cornea. In 2024, 87,349 people received surgical treatment for advanced stage of the disease, and 44.4 million people were treated with antibiotics. Global antibiotic coverage in 2024 was 39%. Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
U.S. doctors warn of a potentially bad year for tick-borne diseases
Tick season seems to be off to a fast start, with an unusually high number of bites already reported across the country.
The hidden signs in your gut that may indicate Parkinson's disease before symptoms emerge
Harvard scientists link gut bacteria to depression through hidden inflammation trigger
A gut bacterium may be quietly fueling depression through an unexpected chemical twist. Researchers found that when Morganella morganii interacts with a common pollutant, it produces a molecule that triggers inflammation—something strongly linked to depression. This finding helps explain how gut microbes can influence brain health at a molecular level. It also raises the possibility of new treatments that target the immune system rather than just the brain.
Is No One Doing Baby Aspirin for Heart Disease Prevention Anymore?
Cardiologists explain.
A Simple Sugar in Ultra-Processed Foods May Drive Obesity, Metabolic Disease
Recent research shows that fructose in ultra-processed foods may drive disease, like metabolic syndrome, which includes obesity. Reducing your intake of this type of simple sugar could help lower the associated health risks.
Lyme disease cases in Michigan rise 168% over 5 years, health officials report
Cases of Lyme disease have seen a 168% increase just in the last five years, according to the Michigan Department of Health and Human Services.
U.S. Forging a Healthier Oceania Through Trump Administration's America First Global Health Strategy Through Bilateral Health Memorandum of Understanding with Papua New Guinea - U.S. Embassy & Consulates in China
United States Forging a Healthier Oceania Through Trump Administration’s America First Global Health Strategy Through Bilateral Health Memorandum of Understanding with Papua New Guinea Press Statement Thomas “Tommy” Pigott, Principal Deputy Spokesperson April 23, 2026 Yesterday the United States and Papua New Guinea signed a five-year bilateral Memorandum of Understanding (MOU) through the Trump Administration’s America First Global Health Strategy. The landmark health MOU focuses on effectively addressing emerging infectious diseases and ongoing outbreaks, building and maintaining surge-response capacities, and enabling Papua New Guinea’s government to independently manage new health threats before they spread internationally. Working with Congress, the United States intends to provide $15 million through December 2030 through the jointly decided health MOU, building on decades of progress in reducing HIV infections and transmissions in Papua New Guinea. The government of Papua New Guinea intends to allocate up to $3 million to disease control programs and strengthen health systems at the national and provincial levels. Up to $5 million under the health MOU will directly support global health security funding, advancing our shared commitment to health security in the region. Through the signing of this $18 million MOU, we are bolstering infectious disease prevention and response by leveraging cost-effective, nationally-driven approaches, with the goal of increasing Papua New Guinea’s health system self-sufficiency. America First Global Health Strategy Memoranda of Understanding (MOUs) signed so far represent more than $20.6 billion in new health funding, including more than $12.8 billion in U.S. assistance alongside $7.8 billion in co-investment from recipient countries, building on decades of progress fighting HIV/AIDS, malaria, tuberculosis, and other infectious diseases around the world. As of April 22, the State Department has signed 32 bilateral global health MOUs with Angola, Bolivia, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon, Côte d’Ivoire, the Democratic Republic of the Congo, the Dominican Republic, El Salvador, Eswatini, Ethiopia, Guatemala, Guinea, Honduras, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mozambique, Niger, Nigeria, Panama, Papua New Guinea, the Philippines, Rwanda, Senegal, Sierra Leone, Tajikistan, and Uganda.
Carrie Ann Inaba shares her struggle to manage hidden, invisible illness: 'It's real'
Carrie Ann Inaba shares her silent struggle with Sjogren's disease, an autoimmune condition that she says went undiagnosed for more than 10 years.
Largest catch-up initiative delivers over 100 million childhood vaccinations
The Big Catch-Up (BCU), a historic multi-year, multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic, has reached an estimated 18.3 million children aged 1 to 5 across 36 countries with more than 100 million doses of life-saving vaccines, helping to narrow critical immunity gaps, announced Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF at the start of World Immunization Week.
Infant Immunization Week highlights vaccines amid rise in preventable illnesses
Health leaders are using National Infant Immunization Week to encourage families to stay informed about childhood vaccines as cases of preventable diseases cont
Abbott, HHSC announce $60M plan to improve rural health
Gov. Greg Abbott and HHSC unveiled $60 million in federal funding to help rural hospital districts expand prevention, wellness and chronic disease programs across Texas.
How Geospatial Science is Reshaping Cancer Epidemiology: Three Perspectives from the Front Lines
The transformational use of geospatial technologies can identify disease risk and outcomes and, more critically, help mitigate cancer mortality.
Vanderbilt Health implants novel device to treat aortic regurgitation in high-risk patients
With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.
Hofstra Guest Speaker Highlights Why Public Health Can No Longer Work in Silos
Public health challenges don’t exist in silos, and neither should their solutions. “The importance of the One Health approach – looking at humans, animals, plants, environments, and ecosystem health – we have to use a broad-based approach when we look at complex diseases,” said Dr. Laura Kahn, a
Healthy Heart, Longer Life: What Cardiologists Want You to Know
Heart disease is largely preventable. Learn expert tips on screenings, lifestyle changes, wearables, and warning signs to protect your heart for life.
Mathews: Mississippi must keep slowing CWD spread until science catches up
I first got involved with the chronic wasting disease issue not long after I started SuperTalk Outdoors. At the time, deer breeders were pushing hard to open
State reports first case of measles this year, warns public exposure could have occurred in Kenner
The Louisiana Department of Health said the patient is thought to have contracted the disease abroad, but visited two Kenner stores last week.
Algeria eliminates trachoma as a public health problem
The World Health Organization (WHO) has validated Algeria as having eliminated trachoma as a public health problem, making it the 10th country in WHO’s African Region and the 29th country globally to achieve this significant milestone.